Two recent studies on antibiotic use may indicate that antibiotic prescribing could be improving over time, but there’s room for improvement. Here’s four takeaways to get even better.
Fleming-Dutra
McDonald
Two recent studies on antibiotic use may indicate that antibiotic prescribing could be improving over time. However, there may be additional opportunities to get even better.
A recent CDC study, published in JAMA Internal Medicine, show that there are still important opportunities to improve antibiotic prescribing in urgent care settings, particularly for respiratory illnesses like colds, flu, and bronchitis which should not be treated with antibiotics.
“Antibiotic stewardship, which is the effort to measure and improve antibiotic use, can help reduce unnecessary antibiotic prescriptions and is needed in all outpatient settings, including urgent care,” says Katherine E. Fleming-Dutra, MD, deputy director, Office of Antibiotic Stewardship, Division of Healthcare Quality Promotion, CDC.
CDC estimates that at least 30% of outpatient antibiotic prescriptions are unnecessary and many more are inappropriate in antibiotic selection, dosing, and duration.
According to Fleming-Dutra, CDC is actively collaborating with organizations in the urgent care space to identify successes, challenges, and opportunities for improvement related to antibiotic use. “Improving the way healthcare professionals prescribe antibiotics, and the way patients take antibiotics, helps keep us healthy now, helps fight antibiotic resistance, and ensures that life-saving antibiotics will be available for future generations,” she says.
Another study by urgent care EHR provider, DocuTAP, examined antibiotic prescribing trends in four categories: antibiotic usage statistics; appropriate vs. inappropriate antibiotic prescribing; antibiotic-inappropriate prescribing based on respiratory condition; and antibiotic prescribing by region. It looked at every urgent care visit that included an E/M (Evaluation and Management) code from July 1, 2017 through June 30, 2018-which excludes most non-urgent care visits like occupational medicine services, sports physicals, and flu shot visits. Total visits represent the count of unique patient visit IDs.
Related: Study defines 'low-value care,' evaluates toll on healthcare industry
DocuTAP determined that antibiotics were inappropriately prescribed in just 6.1% of urgent care visits; and 32.4% of visits to urgent care for respiratory conditions for which antibiotics are ineffective still received prescriptions for antibiotics-13.3% lower than the number reported by the CDC (45.7%).
“Regardless of the reason antibiotic resistance is on the rise, we will do our part as an industry partner to equip urgent care providers with the best technology and resources for effective prescribing practices,” says Eric McDonald, founder and CEO of DocuTAP.
DocuTAP’s research showed that more than half of the urgent care visits included in the study resulted in an antibiotic prescription. Nonsuppurative otitis media was the respiratory condition that resulted in the highest percentage of potential inappropriate antibiotic prescriptions. Both studies found that over 40% of urgent care visits for colds received antibiotics.
McDonald offers these four takeaways about antibiotic prescribing:
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More